Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcomeJulia Asp, Lars Palmqvist, Björn Andréasson et al.|Haematologica|2016Cited by 29
<i>ASXL1</i> mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO‐defined polycythaemia vera patientsBjörn Andréasson, Julia Asp, Carina Wasslavik et al.|British Journal of Haematology|2020Cited by 12
Comparison of Methods for Polycythemia Rubra Vera-1 mRNA Quantification in Whole-Blood Leukocytes and Purified GranulocytesLars Palmqvist, Anne Ricksten, Philipp S. Goerttler et al.|Clinical Chemistry|2004Cited by 4
The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera.Peter Johansson, Björn Andréasson, Berit Johansson et al.|PubMed|2004Cited by 3